INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $48,080 | -83.4% | 107,687 | -42.1% | 0.00% | -100.0% |
| Q4 2022 | $290,115 | -40.7% | 185,971 | -34.4% | 0.00% | -50.0% |
| Q3 2022 | $489,000 | +129.6% | 283,529 | +130.7% | 0.00% | +100.0% |
| Q2 2022 | $213,000 | +432.5% | 122,902 | +1017.3% | 0.00% | – |
| Q1 2022 | $40,000 | -78.6% | 11,000 | -70.7% | 0.00% | -100.0% |
| Q4 2021 | $187,000 | +14.7% | 37,500 | +64.5% | 0.00% | 0.0% |
| Q3 2021 | $163,000 | -68.2% | 22,800 | -58.8% | 0.00% | -60.0% |
| Q2 2021 | $513,000 | -45.5% | 55,351 | -48.0% | 0.01% | -61.5% |
| Q4 2020 | $942,000 | +698.3% | 106,443 | +949.3% | 0.01% | +550.0% |
| Q3 2020 | $118,000 | – | 10,144 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
| STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
| Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
| WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
| Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
| Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
| EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
| Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
| Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |